Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer
- PMID: 16626510
- DOI: 10.1111/j.1745-7254.2006.00306.x
Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer
Abstract
Aim: To study the effect of adenovirus5-mediated human hepatocyte growth factor (Ad(5)-HGF) transfer on post-infarct heart failure in a swine model.
Methods: Twelve young Suzhong swine were randomly divided into 2 groups: the Ad(5)-HGF group (n=6) and the null-Ad(5) group (n=6). Four weeks after left anterior descending coronary artery (LAD) ligation, Ad5-HGF was transferred into the myocardium via the right coronary artery. Coronary angiography and gated cardiac perfusion imaging were performed at the end of 4 and 7 weeks after LAD ligation, respectively, to evaluate collateral artery growth and cardiac perfusion. Then all animals were killed, the expression of HGF and alpha-smooth muscle actin (alpha-SMA) were evaluated by enzyme-linked immunosorbent assay and immunohistochemistry.
Results: Compared with the null-Ad(5) group, higher expression of human HGF was observed in the myocardium in the Ad(5)-HGF group (109.3+/-7.8 vs 6.2+/-2.6, t=30.685, P<0.01). The left ventricular ejection fraction was higher in the Ad(5)-HGF group than in the null-Ad(5) group (43.9+/-4.3 vs 30.4+/-2.8, t=6.514, P<0.01). From the 4th week to the 7th week after operation, left ventricular end systolic volume (42.1+/-3.0 vs 31.0+/-4.9, t=12.800, P<0.01) and left ventricular end diastolic volume (62.2+/-4.2 vs 55.0+/-4.8 t=13.207, P<0.01) were improved in the Ad(5)-HGF group. Cardiac perfusion was significantly improved in the Ad(5)-HGF group. In the Ad(5)-HGF group, growth of collateral arteries was obviously greater (average rank sum 9.17 vs 3.83, n=6, u=-2.687, P<0.01), and the number of alpha-SMA(+) vessels/mm(2) was significantly greater (56.1+/-4.2 vs 16.4+/-3.5, t=17.731, P<0.01) than in the null-Ad(5) group.
Conclusion: High expression levels of human HGF were observed in the myocardium because of non-infarct-related vessel transfer. HGF can increase the number of functional arterioles and improve collateral artery growth. HGF can improve cardiac perfusion and heart function.
Similar articles
-
Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.Gene Ther. 2006 Nov;13(22):1564-8. doi: 10.1038/sj.gt.3302820. Epub 2006 Jun 29. Gene Ther. 2006. PMID: 16810195
-
Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.J Card Surg. 2005 Jan-Feb;20(1):93-101. doi: 10.1111/j.0886-0440.2005.200373.x. J Card Surg. 2005. PMID: 15673421
-
Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine.Clin Chim Acta. 2007 Jun;381(2):114-8. doi: 10.1016/j.cca.2007.02.035. Epub 2007 Feb 23. Clin Chim Acta. 2007. PMID: 17400203
-
Enhancing myocardial plasmid expression by retrograde coronary venous delivery.Catheter Cardiovasc Interv. 2005 Aug;65(4):528-34. doi: 10.1002/ccd.20450. Catheter Cardiovasc Interv. 2005. PMID: 16003788 Review.
-
Roles of hepatocyte growth factor and mast cells in thrombosis and angiogenesis.Cardiovasc Drugs Ther. 2004 Jul;18(4):321-6. doi: 10.1023/B:CARD.0000041252.33870.74. Cardiovasc Drugs Ther. 2004. PMID: 15367830 Review.
Cited by
-
A mouse model for spatial and temporal expression of HGF in the heart.Transgenic Res. 2011 Dec;20(6):1203-16. doi: 10.1007/s11248-011-9485-y. Epub 2011 Mar 1. Transgenic Res. 2011. PMID: 21360304
-
HGF percutaneous endocardial injection induces cardiomyocyte proliferation and rescues cardiac function in pigs.J Biomed Res. 2010 May;24(3):198-206. doi: 10.1016/S1674-8301(10)60029-2. J Biomed Res. 2010. PMID: 23554631 Free PMC article.
-
Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease.Mol Biol Rep. 2009 Jul;36(6):1323-9. doi: 10.1007/s11033-008-9315-3. Epub 2008 Jul 22. Mol Biol Rep. 2009. PMID: 18649012 Clinical Trial.
-
Gene therapy for ischemic heart disease.J Mol Cell Cardiol. 2011 May;50(5):742-50. doi: 10.1016/j.yjmcc.2010.06.007. Epub 2010 Jun 26. J Mol Cell Cardiol. 2011. PMID: 20600100 Free PMC article. Review.
-
Novel therapy for myocardial infarction: can HGF/Met be beneficial?Cell Mol Life Sci. 2011 May;68(10):1703-17. doi: 10.1007/s00018-011-0633-6. Epub 2011 Feb 17. Cell Mol Life Sci. 2011. PMID: 21327916 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical